{"public_id":"cl_1a162f6fe22aa501ad8498b8c2d4a225","status":"active","superseded_by_public_id":null,"corpus_id":251478343,"text":"Brolucizumab binds all VEGF-A isoforms and was recently approved for neovascular age-related macular degeneration.","confidence":0.98,"paper":{"corpus_id":251478343,"title":"Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies","url":"https://sah.borca.ai/papers/251478343"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_06bded63865aa73bb7ef1ee72dba9118","name":"VEGF-A isoforms","description":"The different molecular forms of vascular endothelial growth factor A targeted by brolucizumab.","types":["molecular target"],"url":"https://sah.borca.ai/concepts/co_06bded63865aa73bb7ef1ee72dba9118"},{"public_id":"co_7214aea89ae8736cc8c60353bbca8b4b","name":"neovascular age-related macular degeneration","description":"A form of age-related macular degeneration characterized by choroidal neovascularization and severe vision loss.","types":["disease"],"url":"https://sah.borca.ai/concepts/co_7214aea89ae8736cc8c60353bbca8b4b"},{"public_id":"co_f9a425cd4e805f76e9e439e1d02ca988","name":"brolucizumab","description":"A humanized single-chain antibody fragment that binds VEGF-A and is used by intravitreal injection for retinal disease.","types":["drug","therapeutic agent"],"url":"https://sah.borca.ai/concepts/co_f9a425cd4e805f76e9e439e1d02ca988"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_1a162f6fe22aa501ad8498b8c2d4a225"}